Anixa Biosciences, Inc. (ANIX)

NASDAQ

$2.70

$--

(0.00%)

Pre-Market

Anixa Biosciences, Inc. (ANIX) Live Price Chart

Last updated: ⁦2026-10-21 10:47:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Anixa Biosciences, Inc. (ANIX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.70, with a market capitalization of $90.73M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.32 to $5.46. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$90.73M
Open	$2.70
Day's High	$8.09
Day's Low	$1.33
Previous Close	$2.68
Volume	--
Average Volume	285.18K
P/E Ratio	--
52-Week High	$5.46
52-Week Low	$2.32
Dividend Yield	--
Earnings Date	--

Anixa Biosciences, Inc. (ANIX) Pre-Market Stock Price

Anixa Biosciences, Inc. (ANIX) is trading at $2.70 in pre-market trading as of 2026-10-21 08:01:00, up 0.78% ($0.02) from the previous close of $2.68

Pre-market trading shows how investors are pricing ANIX before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Anixa Biosciences, Inc. (ANIX) 7-Day Stock Price Change

Over the past seven days, Anixa Biosciences, Inc. (ANIX) moved from $2.84 to $2.70, representing a decline of 4.89% ($0.14).

The stock traded between $2.60 and $2.92 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.

The average daily volume was 158.13 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

ANIX 52-Week Price Position

Position in Range: 12.1%

52W Low$2.32

52W High$5.46

ANIX is currently trading at $2.70, placing it 12.1% of the way from its 52-week low of $2.32 to its 52-week high of $5.46. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Anixa Biosciences, Inc. (ANIX)?

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Anixa Biosciences, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	4
Exchange	NASDAQ
Company Website	https://www.anixa.com

How to Buy Anixa Biosciences, Inc. (ANIX) Stock on MEXC

Eligible investors can buy real shares of Anixa Biosciences, Inc. (ANIX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ANIX and Place Your Order

Open the RealStocks trading page and search for ANIX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Anixa Biosciences, Inc. (ANIX) stock price today?

Anixa Biosciences, Inc. (ANIX) is currently trading at $ 2.70, up 0.78% ($0.02) from the previous close of $ 2.68. Intraday prices update in real time during regular trading hours.

2.Is ANIX stock going up or down today?

As of 2026-10-21 08:01:00, ANIX is trading at $ 2.70, up 0.78% ($0.02) from its previous close of $ 2.68. The stock has traded between $ 1.33 and $ 8.09 during today’s regular session. Past price movements do not guarantee future results.

3.What is ANIX pre-market price?

As of 2026-10-21 08:01:00, ANIX is trading at $ 2.70 in pre-market trading, up 0.78% ($0.02) from the previous close of $ 2.68. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ANIX after-hours price?

As of 2026-10-21 08:01:00, ANIX is trading at $ 2.70 in after-hours trading, up 0.82% ($0.02) from the regular-session close of $ 2.68. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ANIX stock trading now?

ANIX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ANIX sit relative to its 52-week high and low?

Over the past 52 weeks, ANIX has traded between a low of $ 2.32 and a high of $ 5.46. At $ 2.70, the stock is positioned 12.1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Anixa Biosciences, Inc. in?

Anixa Biosciences, Inc. (ANIX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Anixa Biosciences, Inc.'s market capitalization and where is it listed?

Anixa Biosciences, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 90.73M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ANIX valued in terms of P/E ratio and EPS?

ANIX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.30. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Anixa Biosciences, Inc. pay a dividend?

Anixa Biosciences, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.